Mario Beer
Impact in
- Otorhinolaryngology top 10%
- Head and Neck Cancer Studies
Papers in
-
- Hematopoietic Stem Cell Transplantation 3
- Acute Myeloid Leukemia Research 2
-
- Head and Neck Cancer Studies 2
- Co-authors
- Paris Kosmidis (10 shared papers)George Fountzilas (10 shared papers)Karen P. Seiter (6 shared papers)Roger M. Phillips (2 shared papers)Y. Kenis (2 shared papers)Rajiv Puri (2 shared papers)Marcel Rozencweig (2 shared papers)Claude Nicaise (2 shared papers)
- Journals
- Annals of Oncology (4 papers)Bone Marrow Transplantation (2 papers)Leukemia (2 papers)European Journal of Cancer (2 papers)Chemotherapy (1 paper)
- Partner nations
- United StatesGreeceSwitzerland
In The Last Decade
Mario Beer
27 papers receiving 408 citations
Peers
Comparison fields: 5 of 33
- Drug Discovery 1
- Otorhinolaryngology 28
- Hematology 50
- Oncology 70
- Cancer Research 22
Countries citing papers authored by Mario Beer
This map shows the geographic impact of Mario Beer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mario Beer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mario Beer more than expected).
Fields of papers citing papers by Mario Beer
This network shows the impact of papers produced by Mario Beer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mario Beer. The network helps show where Mario Beer may publish in the future.
Co-authors
The 25 scholars most cited alongside Mario Beer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1983 | 58 | |
| 2 | 1997 | 43 | |
| 3 | 2009 | 38 | |
| 4 | 2006 | 37 | |
| 5 | 1980 | 25 | |
| 6 | 1992 | 24 | |
| 7 | 1994 | 24 | |
| 8 | 1997 | 24 | |
| 9 | 1992 | 17 | |
| 10 | 1996 | 17 | |
| 11 | 1991 | 15 | |
| 12 | 1996 | 14 | |
| 13 | 1992 | 13 | |
| 14 | 1987 | 11 | |
| 15 | 1991 | 10 | |
| 16 | 2009 | 10 | |
| 17 | TMJ: a well-tolerated high-dose regimen for the adjuvant chemotherapy of high risk breast cancer. | 1994 | 8 |
| 18 | Pentostatin (Nipent) and chlorambucil with granulocyte-macrophage colony-stimulating factor support for patients with previously untreated, treated, and fludarabine-refractory B-cell chronic lymphocytic leukemia. | 2000 | 8 |
| 19 | Cardiotoxicity evaluation in patients treated with a mitoxantrone combination as adjuvant chemotherapy for breast cancer. | 1992 | 7 |
| 20 | 1993 | 7 |
About Mario Beer
Mario Beer is a scholar working on Hematology, Otorhinolaryngology, Oncology, Cancer Research and Surgery, having authored 27 papers that have together received 442 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (3 papers), Hematopoietic Stem Cell Transplantation (3 papers), Acute Myeloid Leukemia Research (2 papers), Lung Cancer Diagnosis and Treatment (2 papers), Head and Neck Cancer Studies (2 papers), Breast Cancer Treatment Studies (2 papers), Chronic Lymphocytic Leukemia Research (1 paper) and Antifungal resistance and susceptibility (1 paper). The work is most often cited by research in Drug Discovery (1 citation), Otorhinolaryngology (28 citations), Hematology (50 citations), Oncology (70 citations) and Cancer Research (22 citations). Mario Beer has collaborated with scholars based in United States, Greece and Switzerland. Frequent co-authors include Paris Kosmidis, George Fountzilas, Karen P. Seiter, Roger M. Phillips, Y. Kenis, Rajiv Puri, Marcel Rozencweig, Claude Nicaise, Tauseef Ahmed and Luigi Lenaz. Their work appears in journals such as Annals of Oncology, Bone Marrow Transplantation, Leukemia, European Journal of Cancer and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.